Helmholtz Institute for Translational AngioCardioScience (HI-TAC)
At HI-TAC, the Max Delbrück Center and Heidelberg University combine expertise in cardiovascular research and systems biology. The establishment of HI-TAC began in July 2023.
The goal of HI-TAC is to investigate mechanisms by which the cardiovascular system mediates interorgan communication addressing influences of metabolism, the nervous system and the immune system. By gaining a better understanding of how changes to blood vessels and the heart trigger pathologies will allow for detection of early warning signs and inform treatments before symptoms occur.
Contact
Dr. Katja Großmann
Chief Research Manager Health
Helmholtz Association
